Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2026-02-25 @ 9:39 PM
Study NCT ID:
NCT01670032
Status:
COMPLETED
Last Update Posted:
2014-08-12
First Post:
2012-08-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo
Sponsor:
NovaBay Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-17
First Submit QC Date:
None
Study First Post Date:
2012-08-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-08-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-08-08
Last Update Post Date:
2014-08-12
Last Update Post Date Type:
ESTIMATED